BALTIMORE (KFSN) -- Thirty million Americans, or one in 10, have some form of liver disease. It could be scarring from a hepatitis C infection, cirrhosis or even liver cancer. Doctors are now using a ...
TEL AVIV, Israel, June 21, 2023 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory ...
Liver stiffness and severe fibrosis, as measured by FibroScan, are independently linked to type 2 diabetes (T2DM) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), new ...
PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan ® portfolio of solutions, is pleased to announce that the “American Association of Clinical ...
RIVERVIEW, Fla. — Laszlo Kolozsvary prides himself for being on top of his health. Florida currently has one of the highest rates of non-alcoholic fatty liver disease (NAFLD) in the U.S., according to ...
Noninvasive liver diagnostic devices are transforming the detection and management of liver disease. The leading device-based solutions showcase this innovative technology and offer numerous clinical ...
Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing significant correlations. Higher scores correlate with increased heart failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results